Spexis Achieves First CARB-X Milestone for its Thanatin Derivatives Program and Receives Funding of up to USD 1.9 Million to Initiate Lead Optimization
ALLSCHWIL, SWITZERLAND / ACCESSWIRE / March 3, 2022 / Spexis AG (SIX:SPEX) announced today that it has been awarded the...